These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 7283399)

  • 41. 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei.
    Rossner S; Härtig W; Schliebs R; Brückner G; Brauer K; Perez-Polo JR; Wiley RG; Bigl V
    J Neurosci Res; 1995 Jun; 41(3):335-46. PubMed ID: 7563226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell loss from the nucleus basalis of Meynert in Alzheimer's disease.
    Doucette R; Fisman M; Hachinski VC; Mersky H
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):435-40. PubMed ID: 3791059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dementia--Alzheimer type.
    Kokmen E
    Mayo Clin Proc; 1984 Jan; 59(1):35-42. PubMed ID: 6694432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neuropathology of Alzheimer's disease and mild cognitive impairment].
    López OL; DeKosky ST
    Rev Neurol; 2003 Jul 16-31; 37(2):155-63. PubMed ID: 12938076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Loss of neurons in the nucleus basalis of Meynert in Parkinson disease with dementia, "diffuse Lewy body disease" and senile dementia of Alzheimer type].
    Yoshimura M; Mori H; Tomonaga M; Yamanouchi H; Kuzuhara S
    Nihon Ronen Igakkai Zasshi; 1984 Nov; 21(6):580-7. PubMed ID: 6533352
    [No Abstract]   [Full Text] [Related]  

  • 46. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
    Hu L; Côté SL; Cuello AC
    Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation.
    Masliah E; Terry R; Buzsáki G
    Brain Res; 1989 Jul; 493(2):240-6. PubMed ID: 2765898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologic effects of nerve growth factor on lesioned basal forebrain neurons.
    Koliatsos VE; Clatterbuck RE; Gouras GK; Price DL
    Ann N Y Acad Sci; 1991; 640():102-9. PubMed ID: 1776727
    [No Abstract]   [Full Text] [Related]  

  • 49. [Nucleus basalis of Meynert and cholinergic neurotransmission].
    Matsushita T; Shimohama S
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():210-3. PubMed ID: 22787783
    [No Abstract]   [Full Text] [Related]  

  • 50. The basal nucleus of Meynert in patients with progressive supranuclear palsy.
    Tagliavini F; Pilleri G; Bouras C; Constantinidis J
    Neurosci Lett; 1984 Jan; 44(1):37-42. PubMed ID: 6717850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer disease: plaques, tangles, and the basal forebrain.
    Whitehouse PJ; Struble RG; Clark AW; Price DL
    Ann Neurol; 1982 Nov; 12(5):494. PubMed ID: 7181455
    [No Abstract]   [Full Text] [Related]  

  • 52. Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases.
    Wurtman RJ; Blusztajn JK; Ulus IH; Coviella IL; Buyukuysal RL; Growdon JH; Slack BE
    Adv Neurol; 1990; 51():117-25. PubMed ID: 2403709
    [No Abstract]   [Full Text] [Related]  

  • 53. Left-right symmetry of neuronal cell counts in the nucleus basalis of Meynert of control and of Alzheimer-diseased brains.
    Doucette R; Ball MJ
    Brain Res; 1987 Oct; 422(2):357-60. PubMed ID: 3676795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.
    Cohen ML; Golde TE; Usiak MF; Younkin LH; Younkin SG
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1227-31. PubMed ID: 3277188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On the question of the relationship of the basal ganglia of Meynert (nucleus ansae lenticularis) with the temporal cortex in man].
    Pilleri G
    J Hirnforsch; 1966; 8(4):343-58. PubMed ID: 5982863
    [No Abstract]   [Full Text] [Related]  

  • 56. [MRI in senile dementia: T1 measurement at the level of the basal ganglia].
    Kakitsubata Y; Watanabe K; Fujimoto T; Kashino Y; Furukubo B; Fujimoto A; Okada A; Yamamoto K
    Rinsho Hoshasen; 1985 Oct; 30(10):1057-9. PubMed ID: 4094109
    [No Abstract]   [Full Text] [Related]  

  • 57. The cholinergic hypothesis--ten years on.
    Perry EK
    Br Med Bull; 1986 Jan; 42(1):63-9. PubMed ID: 3513895
    [No Abstract]   [Full Text] [Related]  

  • 58. Deep brain stimulation for cognitive disorders: insights into targeting nucleus basalis of meynert in Alzheimer dementia.
    Salma A; Vasilakis M; Tracy PT
    World Neurosurg; 2014 Jan; 81(1):e4-5. PubMed ID: 23954461
    [No Abstract]   [Full Text] [Related]  

  • 59. Is alpha-MSH deficiency the cause of Alzheimer's disease?
    Anderson B
    Med Hypotheses; 1986 Apr; 19(4):379-85. PubMed ID: 3635664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical issues of primary dementia].
    Hasegawa K
    Nihon Ronen Igakkai Zasshi; 1984 May; 21(3):236-41. PubMed ID: 6503004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.